CUTE (Chronic Urticaria Treatment Evaluation)

NCT00264303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

886

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Urticaria

Interventions

DRUG: Levocetirizine
DRUG: Desloratadine

Sponsor

UCB Pharma